查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829237

2025年全球分子诊断设备与仪器市场报告

Molecular Diagnostics Devices And Equipment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，分子诊断设备和器械市场规模快速扩张，从2024年的244亿美元成长到2025年的272.3亿美元，复合年增长率为11.6%。这段时期的成长可归因于资金筹措的增加、医疗支出的增加、新兴市场的经济成长、技术的快速进步、新型性行为感染的出现以及老年人口的快速成长。

预计未来几年分子诊断仪器和设备市场规模将快速成长，到 2029 年将达到 425.9 亿美元，复合年增长率为 11.8%。预测期内的增长可归因于各种细菌和病毒性传染病的激增、人口老化、医疗保健机会的增加、慢性病盛行率的上升以及 COVID-19，这些因素将增加对分子诊断仪器和设备的需求。预测期内的主要趋势包括分子诊断领域的自动化、人工智慧的使用、罕见疾病研究中对分子诊断仪器的需求不断增长、巨量资料的日益普及、用于新生儿筛检的下一代定序以及照护现场分子诊断 (POC mdx)。

分子诊断设备透过检测特定的 DNA 或 RNA 序列来诊断和筛检感染疾病，这有助于指导更精确的治疗性介入，特别是在疾病的早期阶段。

分子诊断产品包括仪器、试剂和耗材。本文中的试剂是指用于引发化学反应的物质，通常用于指示某种物质的存在。分子诊断涉及多种技术，包括DNA（去氧核糖核酸）序列测定、聚合酵素链锁反应、恒温核酸增幅技术、转录媒介增幅（TMA）、原位杂合反应、微阵列、质谱、Southern印迹、Northern印迹和电泳。这些技术应用于癌症诊断、药物基因体学、基因检测、感染疾病检测、产前筛检、神经系统疾病分析和心血管疾病评估。分子诊断仪器被各种最终用户使用，包括诊断实验室、医院、老人安养院、血库和照护现场机构。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）全新研究报告系列的一部分，该系列提供分子诊断设备（或器械）市场统计数据，例如全球市场规模、各地区市场份额、竞争对手的市场份额、分子诊断设备（或器械）市场的细分、市场趋势和商机，以及在分子诊断设备（或器械）行业取得成功所需的其他数据。本分子诊断设备（或器材）市场研究报告透过对产业现状和未来趋势的详细分析，为您提供全面的产业展望。

未来五年11.8%的成长预测，较我们先前对该市场的预测略有下降0.3%。下降的主要原因是美国与其他国家之间的关税影响，这将直接影响美国，包括新加坡微流体晶片供应链中断、就地检验设备生产延迟以及感染疾病检测系统成本上升。

感染疾病的日益流行预计将在未来推动分子诊断设备市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等病原微生物引起的疾病，并在人与人之间或从动物传播给人。导致感染疾病增加的因素包括抗生素抗药性、全球化和旅行、都市化、社会经济差距以及人口老化。分子诊断设备和仪器是检测和管理这些疾病的重要工具。例如，2023 年 3 月，英国政府国家统计局报告称，截至 2023 年 3 月 17 日的一周内，英国记录了 619 例与 COVID-19 相关的死亡病例，高于前一周的 605 例。在那一周，COVID-19 死亡人数占英国所有死亡人数的 4.5%，略低于前一周的 4.6%。因此，感染疾病的日益普及正在推动分子诊断设备市场的成长。

慢性病盛行率的不断上升预计将推动分子诊断设备和仪器市场的未来成长。慢性病，又称非传染性疾病 (NCD)，是指进展缓慢且持续较长的健康状况。分子诊断设备和仪器在慢性病的诊断、监测和管理中发挥关键作用，使医疗保健专业人员能够分析与这些疾病相关的遗传、分子和生化标记。例如，2022 年 3 月，美国国家生物技术资讯中心报告称，印度 21% 的老年人患有至少一种慢性病，其中高血压和糖尿病约占所有慢性病的 68%。这凸显了分子诊断在慢性病管理中将扮演的重要角色。

分子诊断产业的主要参与企业正致力于开发用于分子诊断流程的仪器和设备的自动化解决方案。自动化提高了诊断过程的生产力和一致性，与手动方法相比，能够提供更可靠、更有效率的检测结果。基于奈米技术的解决方案，例如用于检测唾液中口腔癌生物标记的口腔液奈米感测器检测 (OFNASET)，正在广泛应用。为了顺应自动化和精准化趋势，罗氏推出了 Cobas 连接模组 (CCM)，该模组透过实现不同系统和仪器之间的自动样品转移，从而提高可扩展性和样品流效率，最终实现完全自动化的工作流程。

分子诊断设备和仪器市场的主要企业正在创新和开发产品，例如用于分子诊断的高性能「样本到结果」仪器。例如，ELITechGroup 于 2023 年 4 月推出了基于其成熟的提取和分析技术的高性能「样本到结果」仪器。该仪器可连续加载样品和试剂，并具有真正的随机存取功能，使用户可以灵活地并行运行不同的 PCR 试剂、通讯协定和样品基质。

2022年2月，印度製造公司Tulip Diagnostics收购了Biosense Technologies，收购金额未揭露。 Tulip Diagnostics旨在透过此次收购提升其就地检验能力并扩展产品系列。 Biosense Technologies也位于印度，专注于开发创新的分子诊断设备，以增强疾病检测能力并提供个人化的医疗保健解决方案。

分子诊断设备和设备市场的主要企业包括 F. Hoffmann-La Roche Ltd、QIAGEN NV、Abbott Laboratories、Danaher Corporation、Biomerieux、Becton Dickinson & Co、Siemens Healthineers AG、Grifols SA、Sysmex Corporation、Abbott India Limited、Qiagen India Limited Scientific、浙江迪安诊断技术股份有限公司、ADICON Clinical Laboratories、广州金域医学检验中心股份有限公司、Kindstar Global、深华大基因、OriGene Technologies、拜耳股份公司、强生公司、Nippon Becton Dickinson Company、QuantuMDx、Your Health、Genefirst、Interlabservis、Geneon Dickinson Company、Mlloxx、Yourest、Genefirst、Interlabservis、GenelinConet. Inc.、诺华股份公司、Cepheid Inc.、Admera Health、安捷伦科技公司AutoGenomics、Bio-Red Laboratories Inc.、Ortho Clinical Diagnostics Inc.、Sysmex Middle East FZ-LLC 和 QIAGEN SA (Pty) Ltd.

2024年，亚太地区是最大的分子诊断设备市场。西欧是第二大分子诊断设备市场。分子诊断设备和仪器市场报告涵盖以下地区：亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

分子诊断设备和设备市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、英国、美国、加拿大、西班牙

分子诊断设备和仪器市场包括热迴圈仪、单粒子质谱仪、飞行时间质谱仪 (TOF) 以及其他用于检测病原体和感染疾病的仪器的销售。此市场的价值以出厂价计算，即商品製造商或生产者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。此市场细分为仪器、试剂和耗材。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球分子诊断设备与仪器：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球分子诊断设备与设备市场：成长率分析
  • 全球分子诊断设备与仪器市场表现：规模与成长，2019-2024
  • 全球分子诊断设备和设备市场预测：规模和成长，2024-2029 年，2034 年
  • 全球分子诊断仪器与设备：总目标市场（TAM）

第六章 市场细分

  • 全球分子诊断设备和设备市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂和耗材
  • 软体
  • 全球分子诊断设备和设备市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • DNA（去氧核糖核酸）序列测定
  • 聚合酵素链锁反应
  • 恒温核酸增幅技术
  • 转录介导扩增（TMA）
  • 原位杂合反应
  • 微阵列
  • 质谱法
  • 其他的
  • 全球分子诊断设备和设备市场的应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 药物基因组学
  • 基因检测
  • 感染疾病
  • 产前
  • 其他的
  • 全球分子诊断设备和设备市场（按最终用户、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 诊断实验室
  • 医院
  • 其他的
  • 全球分子诊断设备和仪器市场：设备细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）设备
  • 核酸分析仪
  • DNA定序仪
  • 微阵列
  • 全球分子诊断设备和仪器市场：试剂和耗材细分、按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • PCR试剂
  • DNA探针和引子
  • 样品製备套件
  • 控制和校准材料
  • 全球分子诊断设备和设备市场：软体细分，按类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 数据分析软体
  • 实验室资讯管理系统（LIMS）
  • 生物资讯软体
  • 测量仪器整合软体

第七章 区域和国家分析

  • 全球分子诊断设备与设备市场：区域表现与预测，2019-2024年，2024-2029年，2034年
  • 全球分子诊断设备与设备市场：国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 分子诊断设备与设备市场：竞争格局
  • 分子诊断设备与设备市场：公司简介
    • F. Hoffmann-La Roche Ltd
    • QIAGEN NV
    • Abbott Laboratories
    • Danaher Corporation
    • Biomerieux

第31章：其他领先和创新企业

  • Becton Dickinson & Co
  • Siemens Healthineers AG
  • Grifols SA
  • Sysmex Corporation
  • Abbott India Limited
  • Qiagen India Pvt Ltd
  • Biocartis
  • Bio-Techne India Private Limited
  • Cleaver Scientific
  • Zhejiang Di'an Diagnostics Technology Co. Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • BGI-Shenzhen
  • OriGene Technologies

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年分子诊断设备与设备市场：提供新机会的国家
  • 2029年分子诊断设备与设备市场：细分市场将带来新机会
  • 2029年分子诊断设备与设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25800u

Molecular diagnostics devices are utilized for the diagnosis of infectious diseases and screening by detecting specific sequences in DNA or RNA. These devices aid in providing more accurate therapeutic interventions, especially in the early stages of a disease.

The main products of molecular diagnostics devices include instruments, reagents, and consumables. Reagents, in this context, refer to substances used to cause a chemical reaction, often employed to indicate the presence of another substance. Various technologies are involved in molecular diagnostics, such as DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription-mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others such as southern blotting, northern blotting, and electrophoresis. These technologies find applications in cancer diagnosis, pharmacogenomics, genetic testing, infectious disease detection, prenatal screening, neurological disease analysis, and cardiovascular disease assessment. Molecular diagnostics devices are used by various end-users, including diagnostic laboratories, hospitals, and others such as nursing homes, blood banks, and point-of-care facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The molecular diagnostics devices (or) equipment market research report is one of a series of new reports from The Business Research Company that provides molecular diagnostics devices (or) equipment market statistics, including molecular diagnostics devices (or) equipment industry global market size, regional shares, competitors with a molecular diagnostics devices (or) equipment market share, detailed molecular diagnostics devices (or) equipment market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics devices (or) equipment industry. This molecular diagnostics devices (or) equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $24.4 billion in 2024 to $27.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rise in funding, increase in healthcare expenditure, economic growth in emerging markets, rapid technological advances, emergence of novel pathogenic infestations, and rapid growth in geriatric population.

The molecular diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $42.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rapid rise in various bacterial and viral epidemics, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for molecular diagnostic devices and equipment due to COVID-19. Major trends in the forecast period include automation in the field of molecular diagnostics, use of artificial intelligence, increased demand for molecular diagnostic devices in studying rare diseases, growing adoption of big data, next generation sequencing for newborn screening, and point-of-care molecular diagnostics (POC mdx).

The forecast of 11.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microfluidic chips from Singapore, delaying production of point-of-care testing devices and increasing costs for infectious disease detection systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of infectious diseases is expected to drive the growth of the molecular diagnostic devices and equipment market in the future. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals or from animals to humans. Factors contributing to the rise in infectious diseases include antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic devices and equipment are critical tools for the detection and management of these diseases. For example, in March 2023, the Office for National Statistics, a UK government department, reported that during the week ending March 17, 2023, the UK recorded 619 deaths related to COVID-19, an increase from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, a slight decrease from 4.6% the week before. Thus, the rising incidence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.

The increasing incidence of chronic diseases is anticipated to drive the future growth of the molecular diagnostics devices and equipment market. Chronic diseases, or non-communicable diseases (NCDs), are persistent health conditions that progress slowly and endure for an extended period. Molecular diagnostics devices and equipment play a crucial role in the diagnosis, monitoring, and management of chronic diseases by enabling healthcare professionals to analyze genetic, molecular, and biochemical markers associated with these conditions. For instance, in March 2022, The National Center for Biotechnology Information reported that 21% of the elderly population in India has at least one chronic disease, with hypertension and diabetes accounting for about 68% of all chronic diseases. This highlights the significant role of molecular diagnostics in managing chronic conditions.

Key players in the molecular diagnostic industry are focusing on developing automated solutions for devices and equipment used in molecular diagnostic processes. Automation enhances productivity and consistency in the diagnostic process, providing reliable and efficient test results compared to manual testing. Nanotechnology-based solutions, such as the Oral Fluid Nano Sensor Test (OFNASET) for detecting oral cancer biomarkers in saliva, are being utilized. To align with the trend of automation and accuracy, Roche introduced cobas connection modules (CCM) to improve scalability and sample-flow efficiency by enabling the automatic movement of samples between different systems and instruments, creating a fully automated workflow.

Major companies in the molecular diagnostics devices and equipment market are innovating by developing products such as high-throughput sample-to-result instruments for molecular diagnostics. ELITechGroup, for instance, launched a high-throughput sample-to-result instrument in April 2023, based on its proven extraction and assay technology. The instrument allows continuous loading of samples and reagents with real random-access capability, providing users with the flexibility to run different PCR reagents, protocols, and sample matrices in parallel.

In February 2022, Tulip Diagnostics, an India-based manufacturing company, acquired Biosense Technologies for an undisclosed amount. With this acquisition, Tulip Diagnostics aims to improve its point-of-care testing capabilities and expand its product portfolio. Biosense Technologies, also based in India, specializes in developing innovative molecular diagnostic devices that enhance disease detection and offer personalized healthcare solutions.

Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomerieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the molecular diagnostics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The molecular diagnostics devices and equipment market consist of sales of thermocycler, single particle mass spectrometers, time-of-flight mass spectrometer (TOF) and others that are used to detect pathogen and infectious diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. This market is segmented into instruments, reagents, and consumables.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Diagnostics Devices And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on molecular diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular diagnostics devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular diagnostics devices and equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments, Reagents And Consumables, Software
  • 2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
  • 3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
  • 4) By End User: Diagnostic laboratories, Hospitals, Other End Users
  • Subsegments:
  • 1) By Instruments: Polymerase Chain Reaction (PCR) Machines; Nucleic Acid Analyzers; DNA Sequencers; Microarrays
  • 2) By Reagents And Consumables: PCR Reagents; DNA Probes And Primers; Sample Preparation Kits; Control And Calibration Materials
  • 3) By Software: Data Analysis Software; Laboratory Information Management Systems (LIMS); Bioinformatics Software; Integration Software For Instrumentation
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; QIAGEN N.V.; Abbott Laboratories; Danaher Corporation; Biomerieux; Becton Dickinson & Co; Siemens Healthineers AG; Grifols S.A.; Sysmex Corporation; Abbott India Limited; Qiagen India Pvt Ltd; Biocartis; Bio-Techne India Private Limited; Cleaver Scientific; Zhejiang Di'an Diagnostics Technology Co. Ltd; ADICON Clinical Laboratories; Guangzhou Kingmed Diagnostics Center Co. Ltd.; Kindstar Global; BGI-Shenzhen; OriGene Technologies; Bayer AG; Johnson & Johnson; Nippon Becton Dickinson Company; QuantuMDx; Yourgene Health; Genefirst; Interlabservis; GeneMe; TestLine; Clinical Diagnostics s.r.o; Hologic Inc.; Illumina Inc.; Novartis AG; Cepheid Inc.; Admera Health; Agilent technologies Inc.; AutoGenomics; Bio-Red Laboratories Inc; Ortho Clinical Diagnostics Inc; Sysmex Middle East FZ-LLC; QIAGEN SA (Pty) Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Devices And Equipment Market Characteristics

3. Molecular Diagnostics Devices And Equipment Market Trends And Strategies

4. Molecular Diagnostics Devices And Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Molecular Diagnostics Devices And Equipment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Molecular Diagnostics Devices And Equipment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Molecular Diagnostics Devices And Equipment Market Growth Rate Analysis
  • 5.4. Global Molecular Diagnostics Devices And Equipment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Molecular Diagnostics Devices And Equipment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Molecular Diagnostics Devices And Equipment Total Addressable Market (TAM)

6. Molecular Diagnostics Devices And Equipment Market Segmentation

  • 6.1. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software
  • 6.2. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA(Deoxyribonucleic acid) sequencing
  • Polymerase chain reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Transcription Mediated Amplification (TMA)
  • In situ hybridization
  • Microarrays
  • Mass spectrometry
  • Other Technologies
  • 6.3. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Pharmacogenomics
  • Genetic testing
  • Infectious disease
  • Prenatal
  • Other Applications
  • 6.4. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic laboratories
  • Hospitals
  • Other End Users
  • 6.5. Global Molecular Diagnostics Devices And Equipment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Machines
  • Nucleic Acid Analyzers
  • DNA Sequencers
  • Microarrays
  • 6.6. Global Molecular Diagnostics Devices And Equipment Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • DNA Probes And Primers
  • Sample Preparation Kits
  • Control And Calibration Materials
  • 6.7. Global Molecular Diagnostics Devices And Equipment Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Laboratory Information Management Systems (LIMS)
  • Bioinformatics Software
  • Integration Software For Instrumentation

7. Molecular Diagnostics Devices And Equipment Market Regional And Country Analysis

  • 7.1. Global Molecular Diagnostics Devices And Equipment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Molecular Diagnostics Devices And Equipment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Molecular Diagnostics Devices And Equipment Market

  • 8.1. Asia-Pacific Molecular Diagnostics Devices And Equipment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Molecular Diagnostics Devices And Equipment Market

  • 9.1. China Molecular Diagnostics Devices And Equipment Market Overview
  • 9.2. China Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Molecular Diagnostics Devices And Equipment Market

  • 10.1. India Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Molecular Diagnostics Devices And Equipment Market

  • 11.1. Japan Molecular Diagnostics Devices And Equipment Market Overview
  • 11.2. Japan Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Molecular Diagnostics Devices And Equipment Market

  • 12.1. Australia Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Molecular Diagnostics Devices And Equipment Market

  • 13.1. Indonesia Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Molecular Diagnostics Devices And Equipment Market

  • 14.1. South Korea Molecular Diagnostics Devices And Equipment Market Overview
  • 14.2. South Korea Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Molecular Diagnostics Devices And Equipment Market

  • 15.1. Western Europe Molecular Diagnostics Devices And Equipment Market Overview
  • 15.2. Western Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Molecular Diagnostics Devices And Equipment Market

  • 16.1. UK Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Molecular Diagnostics Devices And Equipment Market

  • 17.1. Germany Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Molecular Diagnostics Devices And Equipment Market

  • 18.1. France Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Molecular Diagnostics Devices And Equipment Market

  • 19.1. Italy Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Molecular Diagnostics Devices And Equipment Market

  • 20.1. Spain Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Molecular Diagnostics Devices And Equipment Market

  • 21.1. Eastern Europe Molecular Diagnostics Devices And Equipment Market Overview
  • 21.2. Eastern Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Molecular Diagnostics Devices And Equipment Market

  • 22.1. Russia Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Molecular Diagnostics Devices And Equipment Market

  • 23.1. North America Molecular Diagnostics Devices And Equipment Market Overview
  • 23.2. North America Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Molecular Diagnostics Devices And Equipment Market

  • 24.1. USA Molecular Diagnostics Devices And Equipment Market Overview
  • 24.2. USA Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Molecular Diagnostics Devices And Equipment Market

  • 25.1. Canada Molecular Diagnostics Devices And Equipment Market Overview
  • 25.2. Canada Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Molecular Diagnostics Devices And Equipment Market

  • 26.1. South America Molecular Diagnostics Devices And Equipment Market Overview
  • 26.2. South America Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Molecular Diagnostics Devices And Equipment Market

  • 27.1. Brazil Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Molecular Diagnostics Devices And Equipment Market

  • 28.1. Middle East Molecular Diagnostics Devices And Equipment Market Overview
  • 28.2. Middle East Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Molecular Diagnostics Devices And Equipment Market

  • 29.1. Africa Molecular Diagnostics Devices And Equipment Market Overview
  • 29.2. Africa Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Molecular Diagnostics Devices And Equipment Market Competitive Landscape And Company Profiles

  • 30.1. Molecular Diagnostics Devices And Equipment Market Competitive Landscape
  • 30.2. Molecular Diagnostics Devices And Equipment Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Biomerieux Overview, Products and Services, Strategy and Financial Analysis

31. Molecular Diagnostics Devices And Equipment Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson & Co
  • 31.2. Siemens Healthineers AG
  • 31.3. Grifols S.A.
  • 31.4. Sysmex Corporation
  • 31.5. Abbott India Limited
  • 31.6. Qiagen India Pvt Ltd
  • 31.7. Biocartis
  • 31.8. Bio-Techne India Private Limited
  • 31.9. Cleaver Scientific
  • 31.10. Zhejiang Di'an Diagnostics Technology Co. Ltd
  • 31.11. ADICON Clinical Laboratories
  • 31.12. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.13. Kindstar Global
  • 31.14. BGI-Shenzhen
  • 31.15. OriGene Technologies

32. Global Molecular Diagnostics Devices And Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Molecular Diagnostics Devices And Equipment Market

34. Recent Developments In The Molecular Diagnostics Devices And Equipment Market

35. Molecular Diagnostics Devices And Equipment Market High Potential Countries, Segments and Strategies

  • 35.1 Molecular Diagnostics Devices And Equipment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Molecular Diagnostics Devices And Equipment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Molecular Diagnostics Devices And Equipment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer